Defective repression of c-myc in breast cancer cells:: A loss at the core of the transforming growth factor β growth arrest program

被引:269
作者
Chen, CR
Kang, YB
Massagué, J
机构
[1] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA
[2] Howard Hughes Med Inst, New York, NY 10021 USA
关键词
D O I
10.1073/pnas.98.3.992
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Loss of growth inhibitory responses to the cytokine transforming growth factor beta (TGF-beta) in cancer cells may result from mutational inactivation of TGF-beta receptors or their signal transducers, the Smad transcription factors. In breast cancer, however, loss of TGF-beta growth inhibition often occurs without a loss of these signaling components. A genome-wide analysis of rapid TGF-beta gene responses in MCF-10A human mammary epithelial cells and MDA-MB-231 breast cancer cells shows that c-myc repression, a response that is key to the TGF-beta program of cell cycle arrest, is selectively lost in the cancer cell line. Transformation of MCF-10A cells with c-Ha-ras and c-erbB2 oncogenes also led to a selective loss of c-myc repression and cell cycle arrest response. TGF-beta stimulation of epithelial cells rapidly induces the formation of a Smad complex that specifically recognizes a TGF-beta inhibitory element in the c-myc promoter. Formation of this complex is deficient in the oncogenically transformed breast cells. These results suggest that a Smad complex that specifically mediates c-myc repression is a target of oncogenic signals in breast cancer.
引用
收藏
页码:992 / 999
页数:8
相关论文
共 71 条
[1]  
ALEXANDROW MG, 1995, CANCER RES, V55, P1452
[2]  
Anbazhagan R, 1999, CANCER RES, V59, P3363
[3]   Transforming growth factor-β and breast cancer -: Mammary gland development [J].
Barcellos-Hoff, MH ;
Ewan, KBR .
BREAST CANCER RESEARCH, 2000, 2 (02) :92-99
[4]   Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) with cyclin A-Cdk2 and cyclin D2-Cdk4 [J].
Blain, SW ;
Montalvo, E ;
Massague, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (41) :25863-25872
[5]   Smad4/DPC4 silencing and hyperactive Ras jointly disrupt transforming growth factor-β antiproliferative responses in colon cancer cells [J].
Calonge, MJ ;
Massagué, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (47) :33637-33643
[6]   ADDITIVE EFFECTS OF C-ERBB-2, C-HA-RAS, AND TRANSFORMING GROWTH FACTOR-ALPHA GENES ON INVITRO TRANSFORMATION OF HUMAN MAMMARY EPITHELIAL-CELLS [J].
CIARDIELLO, F ;
GOTTARDIS, M ;
BASOLO, F ;
PEPE, S ;
NORMANNO, N ;
DICKSON, RB ;
BIANCO, AR ;
SALOMON, DS .
MOLECULAR CARCINOGENESIS, 1992, 6 (01) :43-52
[7]   A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor β-induced cell-cycle arrest [J].
Claassen, GF ;
Hann, SR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (17) :9498-9503
[8]   Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion [J].
Coller, HA ;
Grandori, C ;
Tamayo, P ;
Colbert, T ;
Lander, ES ;
Eisenman, RN ;
Golub, TR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3260-3265
[9]  
Dang CV, 1999, MOL CELL BIOL, V19, P1
[10]   FUNCTIONAL-ANALYSIS OF THE TRANSFORMING GROWTH-FACTOR-BETA RESPONSIVE ELEMENTS IN THE WAF1/CIP1/P21 PROMOTER [J].
DATTO, MB ;
YU, Y ;
WANG, XF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (48) :28623-28628